Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioImagene Provides Global Digital Solutions in Indian Pathology Market.


PUNE, India -- BioImagene Inc., the Silicon Valley based Image Informatics company today announced the launching of its Digital Pathology solutions for the Indian market. The announcement was made at the XII(th) International CME CME

See: Chicago Mercantile Exchange


CME

See Chicago Mercantile Exchange (CME).
 (Continuing Medical Education continuing medical education See CME. ) in Surgical Pathology surgical pathology
n.
A field in anatomical pathology concerned with examination of surgical specimens of tissues removed from living patients for the purpose of diagnosis of disease and guidance in the care of patients.
 and Cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. , hosted in Pune, January 18-20.

Having successfully established its presence in the U.S digital pathology market, BioImagene is viewing the Indian market to expand its global outreach. BioImagene's technological offering is a complete end-to-end solution (jargon) end-to-end solution - (E2ES) A term that suggests that the supplier of an application program or system will provide all the hardware and/or software components and resouces to meet the customer's requirement and no other supplier need be involved.

Compare: turn-key solution.
. This will enable scientists and pathologists to implement a comprehensive scientific data/image management, processing and analysis solution where image data and metadata will be accessed, viewed and analyzed securely through a web browser The program that serves as your front end to the Web on the Internet. In order to view a site, you type its address (URL) into the browser's Location field; for example, www.computerlanguage.com, and the home page of that site is downloaded to you. . The system's flexibility would support remote consultations for projects focused on the cancer market.

BioImagene's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Mr. Mohan Uttarwar said, "BioImagene would like to take digital pathology to a whole new level by making it easy and affordable for pathologists to manage, analyze, share, and report on their images with simple mouse clicks."

Dr. Kerschmann, Chief of Space Biosciences, NASA Ames Research Center NASA Ames Research Center (ARC) is a NASA facility located at Moffett Federal Airfield, which covers 43 acres at the borders of the cities of Mountain View and Sunnyvale in California. This research center is most commonly called NASA Ames.  who is in India to speak at CME said, "With escalating healthcare costs and shortage of qualified physicians in developed countries, Digital Pathology solutions provide great global opportunities for available lower cost markets like India."

Dr. Pradhan, Organizing Chairman of Pune CME 2007 said, "BioImagene's solutions mark the start of a hi-tech digital era in pathology imaging technology. This will benefit pathologists by:

* Digitization of glass slides and their better visualization on a computer screen.

* Simultaneous image access for more than one pathologist, easing peer review/second opinion processes with online sharing and collaboration of images.

* Image manipulation to assist in sub specialties like immunohistochemistry, cytology especially pap smears."

BioImagene is leading the way to provide a comprehensive digital pathology solution encompassing image/data management, processing, analysis, reporting, and collaboration.

About BioImagene

BioImagene, Inc., based in Cupertino, California, is a leading provider of image informatics solutions for digital pathology, life sciences research, and drug discovery & development. BioImagene has developed a line of products from the flagship management platform 3i. BioImagene's image informatics technology integrates valuable image and non-image data, allowing researchers, scientists, and pathologists to search, track, share, analyze and report data/images. BioImagene products are for research use only.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 19, 2007
Words:375
Previous Article:VIOXX(R) Plaintiffs Failed to Prove Their Cases.
Next Article:Majestic Realty Co. Lauds Governor Schwarzenegger for Release of Goods Movement Action Plan.
Topics:



Related Articles
Lab results on-line to doctors surgery. (Security).
Educational software. (Product Marketplace).
Bioimagene Launches; Introduces an Innovative Solution to Enable Digital Pathology.
BioImagene Announces US Labs as Its First Strategic Customer to Launch an Innovative Digital Pathology Solution.
BioImagene Secured $4.2 Million in Series B Financing Led by Tuputele Ventures and Authosis Ventures.
Indian Summit '05 showed TV gains.
BioImagene to Present at Medtech Insight and Windhover Information's ''In3 Medical Device Summit'' Conference, June 21-23, 2006 in San Francisco, CA.
The future of IP hosted services: A Q & A session with Rich Tehrani and EagleACD's Kent Charugundla.
BioImagene Introduces Pathiam(TM) 3.0 (RUO)(1) - A Comprehensive and Affordable Digital Pathology Solution.
BioImagene Receives FDA Clearance for HER2/neu Application on Pathiam(TM) Imaging Software.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles